[HTML][HTML] Incremental innovation and progress in advanced squamous cell lung cancer: current status and future impact of treatment
CJ Langer, C Obasaju, P Bunn, P Bonomi… - Journal of Thoracic …, 2016 - Elsevier
Squamous cell lung cancer (sqCLC) is an aggressive form of cancer that poses many
therapeutic challenges. Patients tend to be older, present at a later stage, and have a high …
therapeutic challenges. Patients tend to be older, present at a later stage, and have a high …
[HTML][HTML] Current and emergent therapy options for advanced squamous cell lung cancer
Squamous cell lung cancer (SqCLC) is a distinct histologic subtype of NSCLC that is
challenging to treat because of specific clinicopathologic characteristics, which include older …
challenging to treat because of specific clinicopathologic characteristics, which include older …
New developments in the treatment of squamous cell lung cancer
M Filipits - Current opinion in oncology, 2014 - journals.lww.com
New developments in the treatment of squamous cell lung canc... : Current Opinion in
Oncology New developments in the treatment of squamous cell lung cancer : Current …
Oncology New developments in the treatment of squamous cell lung cancer : Current …
[HTML][HTML] Treatment considerations for patients with advanced squamous cell carcinoma of the lung
ES Santos, E Rodriguez - Clinical Lung Cancer, 2022 - Elsevier
Squamous cell carcinoma (SCC) of the lung has a markedly different molecular profile to
adenocarcinoma of the lung and remains difficult to treat because of the lack of targeted …
adenocarcinoma of the lung and remains difficult to treat because of the lack of targeted …
Current state-of-the-art therapy for advanced squamous cell lung cancer
GV Scagliotti, S Novello, S Rapetti… - American Society of …, 2013 - ascopubs.org
Squamous cell carcinoma (SCC) represents the second most common histologic subtype of
lung cancer (preceded only by adenocarcinoma). SSC of the lung is prevalently diagnosed …
lung cancer (preceded only by adenocarcinoma). SSC of the lung is prevalently diagnosed …
Personalized therapy on the horizon for squamous cell carcinoma of the lung
HS Kim, T Mitsudomi, RA Soo, BC Cho - Lung cancer, 2013 - Elsevier
Squamous cell carcinoma (SQCC) of the lung is the second-largest subtype of non-small
cell lung cancer (NSCLC), causing an estimated 400,000 deaths per year worldwide …
cell lung cancer (NSCLC), causing an estimated 400,000 deaths per year worldwide …
Squamous cell lung cancer: from tumor genomics to cancer therapeutics
DR Gandara, PS Hammerman, ML Sos, PN Lara Jr… - Clinical cancer …, 2015 - AACR
Squamous cell lung cancer (SCC) represents an area of unmet need in lung cancer
research. For the past several years, therapeutic progress in SCC has lagged behind the …
research. For the past several years, therapeutic progress in SCC has lagged behind the …
Emerging drugs for squamous cell lung cancer
H Cheng, M Shcherba, K Kandavelou… - Expert Opinion on …, 2015 - Taylor & Francis
Introduction: The management of advanced NSCLC has been shifted by histology-driven
treatment and molecularly targeted therapy, especially in lung adenocarcinoma. However …
treatment and molecularly targeted therapy, especially in lung adenocarcinoma. However …
Second-line therapy of squamous non-small cell lung cancer: an evolving landscape
C Lazzari, N Karachaliou, V Gregorc… - Expert Review of …, 2017 - Taylor & Francis
Introduction: The treatment of lung cancer has radically changed over the last few years. The
discovery of druggable oncogenic alterations and the introduction of immunotherapy have …
discovery of druggable oncogenic alterations and the introduction of immunotherapy have …
New treatment options in advanced squamous cell lung cancer
PK Paik, RN Pillai, CS Lathan, SA Velasco… - American Society of …, 2019 - ascopubs.org
The past few years have witnessed a rapid shift in the treatments for patients with squamous
cell lung cancers (SQCLCs) after the US Food and Drug Administration approval of a …
cell lung cancers (SQCLCs) after the US Food and Drug Administration approval of a …